These findings demonstrate that θ′ alternans was marked in the flecainide-treated Scn5a+/− RV epicardium, which is the site previously implicated in the initiation of arrhythmia (Matthews et al. 2012), potentially suggesting their role in the arrhythmogenic mechanism. The gene discussed is SCN5A; the disease is Arrhythmia.